scholarly journals Adoption of Transcatheter Aortic Valve Implantation in Western Europe

2011 ◽  
Vol 9 (1) ◽  
pp. 37 ◽  
Author(s):  
Darren Mylotte ◽  
Ruben LJ Osnabrugge ◽  
Giuseppe Martucci ◽  
Ruediger Lange ◽  
Arie Pieter Kappetein ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Western Europe ◽  
Therapeutic Option ◽  
Surgical Aortic Valve Replacement ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Transcatheter aortic valve implantation (TAVI) is a novel therapeutic option for patients with severe symptomatic aortic stenosis (AS) at excessive or high surgical risk for conventional surgical aortic valve replacement. First commercialised in Europe in 2007, TAVI growth has been exponential among some Western European nations, though recent evidence suggests heterogeneous adoption of this new and expensive therapy. Herein, we review the evidence describing the utilisation of TAVI in Western Europe.

scholarly journals Transcatheter aortic valve implantation: Results of a new therapeutic option for high surgical risk aortic stenosis

2012 ◽  
Vol 31 (2) ◽  
pp. 143-149
Author(s):  
Pablo Salinas ◽  
Raul Moreno ◽  
Luis Calvo ◽  
David Dobarro ◽  
Santiago Jiménez-Valero ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Transcatheter Aortic Valve Implantation ◽  
Therapeutic Option ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Outcomes of Transcatheter Aortic Valve Implantation in Patients With Low Versus Intermediate to High Surgical Risk

2019 ◽  
Vol 123 (4) ◽  
pp. 644-649 ◽  
Author(s):  
Ariel Finkelstein ◽  
Zach Rozenbaum ◽  
Amir Halkin ◽  
Shmuel Banai ◽  
Samuel Bazan ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Outcomes of Patients With Severe Aortic Stenosis at High Surgical Risk Evaluated in a Trial of Transcatheter Aortic Valve Implantation

2012 ◽  
Vol 110 (7) ◽  
pp. 1008-1014 ◽  
Author(s):  
Itsik Ben-Dor ◽  
Danny Dvir ◽  
Israel M. Barbash ◽  
Petros Okubagzi ◽  
Rebecca Torguson ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Transcatheter Aortic Valve Implantation ◽  
Severe Aortic Stenosis ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

scholarly journals Seven-year survival after transapical transcatheter aortic valve implantation for intermediate and high surgical risk or inoperable patients

Cor et Vasa ◽  
2021 ◽  
Vol 63 (1) ◽  
pp. 90-91
Author(s):  
Michal Hulman ◽  
Martin Beňa ◽  
Ivo Gasparovič ◽  
Vladan Hudec ◽  
Branislav Bezák ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

scholarly journals Endovascular Bail Out for a Failed Transcatheter Aortic Valve Implantation in High Surgical Risk Patient

2021 ◽  
Vol 2021 ◽  
pp. 1-4
Author(s):  
Ilaria Peluttiero ◽  
Alessandro Robaldo ◽  
Luigi Leotta ◽  
Claudio Novali
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Acute Type ◽  
Emergency Setting ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
Acute Type A Dissection ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

The endovascular treatment for acute type A dissection (ATAD) represents an alternative and emerging option in selected high surgical risk patients. We report a successful total endovascular ATAD repair occurred intraoperatively during transcatheter aortic valve implantation (TAVI) placement in 82 years old female, not fit for surgery in emergency setting. The presentation, the diagnostic evaluation, and the technique are discussed. This case would support the feasibility and efficacy of the stent graft technology to treat ATADs after evaluation of clinical, anatomical, and radiological parameters.

scholarly journals Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis

2019 ◽  
Vol 40 (38) ◽  
pp. 3143-3153 ◽  
Author(s):  
George C M Siontis ◽  
Pavel Overtchouk ◽  
Thomas J Cahill ◽  
Thomas Modine ◽  
Bernard Prendergast ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Transcatheter Aortic Valve Implantation ◽  
Severe Aortic Stenosis ◽  
Surgical Aortic Valve Replacement ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
All Cause Mortality ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Abstract Aims  Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) vs. surgical aortic valve replacement (SAVR) across the entire spectrum of surgical risk patients. Methods and results  The meta-analysis is registered with PROSPERO (CRD42016037273). We identified RCTs comparing TAVI with SAVR in patients with severe aortic stenosis reporting at different follow-up periods. We extracted trial, patient, intervention, and outcome characteristics following predefined criteria. The primary outcome was all-cause mortality up to 2 years for the main analysis. Seven trials that randomly assigned 8020 participants to TAVI (4014 patients) and SAVR (4006 patients) were included. The combined mean STS score in the TAVI arm was 9.4%, 5.1%, and 2.0% for high-, intermediate-, and low surgical risk trials, respectively. Transcatheter aortic valve implantation was associated with a significant reduction of all-cause mortality compared to SAVR {hazard ratio [HR] 0.88 [95% confidence interval (CI) 0.78–0.99], P = 0.030}; an effect that was consistent across the entire spectrum of surgical risk (P-for-interaction = 0.410) and irrespective of type of transcatheter heart valve (THV) system (P-for-interaction = 0.674). Transcatheter aortic valve implantation resulted in lower risk of strokes [HR 0.81 (95% CI 0.68–0.98), P = 0.028]. Surgical aortic valve replacement was associated with a lower risk of major vascular complications [HR 1.99 (95% CI 1.34–2.93), P = 0.001] and permanent pacemaker implantations [HR 2.27 (95% CI 1.47–3.64), P < 0.001] compared to TAVI. Conclusion  Compared with SAVR, TAVI is associated with reduction in all-cause mortality and stroke up to 2 years irrespective of baseline surgical risk and type of THV system.

Sign in / Sign up

Export Citation Format

Share Document